Integra Lifesciences Holdings (IART) Cash from Investing Activities Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.89% |
| Dec 31, 2025 | 0.57% |
| Sep 30, 2025 | -18.33% |
| Jun 30, 2025 | -40.54% |
| Mar 31, 2025 | -10.83% |
| Dec 31, 2024 | 27.08% |
| Sep 30, 2024 | 37.48% |
| Jun 30, 2024 | -79.24% |
| Mar 31, 2024 | -27.84% |
| Dec 31, 2023 | -17.71% |
| Sep 30, 2023 | 13.98% |
| Jun 30, 2023 | -70.20% |
| Mar 31, 2023 | -8.07% |
| Dec 31, 2022 | 43.87% |
| Sep 30, 2022 | 32.49% |
| Jun 30, 2022 | 34.57% |
| Mar 31, 2022 | 40.78% |
| Dec 31, 2021 | -5.39% |
| Sep 30, 2021 | -4.79% |
| Jun 30, 2021 | 0.32% |
| Mar 31, 2021 | -77.20% |
| Dec 31, 2020 | 1.02% |
| Sep 30, 2020 | 53.69% |
| Jun 30, 2020 | 16.32% |
| Mar 31, 2020 | -59.81% |
| Dec 31, 2019 | 26.92% |
| Sep 30, 2019 | -65.47% |
| Jun 30, 2019 | -13.23% |
| Mar 31, 2019 | 42.26% |
| Dec 31, 2018 | -40.80% |
| Sep 30, 2018 | -4.06% |
| Jun 30, 2018 | 15.91% |
| Mar 31, 2018 | 6.61% |
| Dec 31, 2017 | -101.28% |
| Sep 30, 2017 | -18.72% |
| Jun 30, 2017 | -46.69% |
| Mar 31, 2017 | -24.79% |
| Dec 31, 2016 | -6.30% |
| Sep 30, 2016 | 39.22% |
| Jun 30, 2016 | 38.03% |
| Mar 31, 2016 | -2.59% |
| Dec 31, 2015 | -14.46% |
| Sep 30, 2015 | -103.87% |
| Dec 31, 2014 | -8.00% |
| Sep 30, 2014 | -0.27% |